Newswise: AI more accurately identifies patients with advanced lung cancer that respond to immunotherapy and helps doctors select treatments

Newswise: AI more accurately identifies patients with advanced lung cancer that respond to immunotherapy and helps doctors select treatments. “Treatment planning for lung cancer can often be complex due to variations in assessing immune biomarkers. In a new study, Yale Cancer Center researchers at Yale School of Medicine used artificial intelligence (AI) tools and digital pathology to improve the accuracy of this process.”